Biotech in Asia: looking forward to 2023
Masahiko Hayakawa, head of targeted protein degradation at Astellas Pharma Inc., gives us some insights…
January 11, 2023 - 4 minutes
Astellas Pharma
Selecta and Astellas sign LOPD treatment agreement
Selecta Biosciences, Inc. and Astellas Pharma Inc. have announced an exclusive licensing and development agreement…
January 9, 2023 - 3 minutes
Japanese companies look to reduce environmental impact
Japanese companies Astellas Pharma Inc., Eisai Co., Ltd., Daiichi Sankyo Company, Limited, and Takeda Pharmaceutical…
December 22, 2022 - 2 minutes
Astellas gastric cancer drug meets phase 3 primary endpoint
Astellas Pharma Inc. has announced positive topline results from the phase 3 GLOW clinical trial…
December 16, 2022 - 3 minutes
Astellas meets primary endpoint in gastric cancer study
Astellas Pharma Inc. has announced positive topline results from its phase 3 SPOTLIGHT clinical trial…
November 17, 2022 - 4 minutes
Astellas and Pantherna to work together on mRNA-based medicine through direct reprogramming
Astellas Pharma Inc. and Pantherna Therapeutics GmbH have entered into a new technology evaluation agreement…
October 4, 2022 - 2 minutes
Treatment for hot flushes and night sweats accepted for regulatory review by EMA
A treatment for moderate to severe vasomotor symptoms (VMS) has been accepted by the European…
September 30, 2022 - 2 minutes
Astellas, Seagen and Merck give details on urothelial cancer treatment
Astellas Pharma Inc., Seagen Inc. and Merck (known as MSD outside of the U.S. and…
September 12, 2022 - 5 minutes
Astellas ‘encouraged’ by menopause symptom treatment results in China
Astellas Pharma Inc. has announced topline results from its phase 3 MOONLIGHT 3 clinical trial…
September 5, 2022 - 4 minutes
Astellas to create new biotech campus in South San Francisco
Astellas Pharma Inc. has unveiled plans to create an integrated biotechnology campus in South San…
July 22, 2022 - 2 minutes
Mogrify and Astellas to address sensorineural hearing loss
Biopharma company Mogrify Limited, and Japanese regenerative medicine firm Astellas Pharma Inc., have announced a…
July 5, 2022 - 2 minutes
Anti-Aging Treatments at Forefront of Astellas’ €80M UK Acquisition
Japanese pharma giant Astellas has acquired the UK biotech Nanna Therapeutics for up to €80M…
April 28, 2020 - 3 minutes
